| abstract |
Compositions comprising the cancer drug N-2(2-((4-hydroxyphenyl) amino)pyrid-3-yl)-4-methoxybenzenesulfonamide (ABT-751), continuous oral dosing schedule with said drug which binds to the colchicine site of tubulin ß-subunits, and methods of treating diseases using continuous dosing schedules are disclosed. |